Literature DB >> 16523183

Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?

C Renard1, E Van Obberghen.   

Abstract

Diabetes mellitus is associated with a greater risk of developing atherosclerosis and its complications: stroke, myocardial infarction, and peripheral vascular disease. In patients with diabetes, atherosclerosis represents a complex multifactorial disease with increased lesion progression and severity compared to the nondiabetic population. Several risk factors have been proposed to explain the increased risk of cardiovascular disease with diabetes. They include: hyperglycaemia, dyslipidemia, accelerated formation of advanced glycation end-products (AGEs), increased oxidative stress, and genetic factors. It is difficult to precisely establish the elements leading to diabetes-accelerated atherosclerosis by means of epidemiological studies because all these factors coexist in diabetic patients. Thus, diabetic animal models that reproduce exacerbation of atherosclerosis would be helpful to understand why atherosclerosis is accelerated by diabetes, and to design appropriate treatments to limit its progression. This review analyzes most of the animal models developed to reproduce diabetes-accelerated atherosclerosis, and summarizes the effects of hyperglycaemia and lipid abnormalities on atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523183     DOI: 10.1016/s1262-3636(07)70243-4

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  9 in total

1.  High glucose-treated macrophages augment E-selectin expression in endothelial cells.

Authors:  Te-Chuan Chen; Shao-Ju Chien; Hsing-Chun Kuo; Wen-Shih Huang; Jiunn-Ming Sheen; Tseng-Hsi Lin; Chia-Kuang Yen; Mao-Lin Sung; Cheng-Nan Chen
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

2.  Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully 'switchable' in vivo mouse model of diabetes.

Authors:  S Zervou; Y-F Wang; A Laiho; A Gyenesei; L Kytömäki; R Hermann; S Abouna; D Epstein; S Pelengaris; M Khan
Journal:  Diabetologia       Date:  2010-09-16       Impact factor: 10.122

3.  Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria.

Authors:  Kai Soo Tan; Kok Onn Lee; Kee Chung Low; Akshamal Mihiranga Gamage; Yichun Liu; Gek-Yen Gladys Tan; Hui Qi Vanessa Koh; Sylvie Alonso; Yunn-Hwen Gan
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

4.  Combination of Medicinal Herbs KIOM-79 Reduces Advanced Glycation End Product Accumulation and the Expression of Inflammatory Factors in the Aorta of Zucker Diabetic Fatty Rats.

Authors:  Eunjin Sohn; Junghyun Kim; Il Ha Jeong; Chan Sik Kim; Young Sook Kim; Jin Sook Kim
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-15       Impact factor: 2.629

5.  Adipophilin affects the expression of TNF-alpha, MCP-1, and IL-6 in THP-1 macrophages.

Authors:  F L Chen; Z H Yang; X C Wang; Y Liu; Y H Yang; L X Li; W C Liang; W B Zhou; R M Hu
Journal:  Mol Cell Biochem       Date:  2009-10-23       Impact factor: 3.396

6.  Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase.

Authors:  Kazuhiro Omori; Taisuke Ohira; Yushi Uchida; Srinivas Ayilavarapu; Eraldo L Batista; Motohiko Yagi; Tomoyuki Iwata; Hongsheng Liu; Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  J Leukoc Biol       Date:  2008-04-07       Impact factor: 4.962

7.  Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.

Authors:  Timothy C Nichols; Elizabeth P Merricks; Dwight A Bellinger; Robin A Raymer; Jing Yu; Diana Lam; Gary G Koch; Walker H Busby; David R Clemmons
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.

Authors:  Michèle Geoffrion; Xueliang Du; Zehra Irshad; Barbara C Vanderhyden; Kerri Courville; Guangzhi Sui; Vivette D D'Agati; Sylvie Ott-Braschi; Naila Rabbani; Paul J Thornalley; Michael Brownlee; Ross W Milne
Journal:  Physiol Rep       Date:  2014-06-11

9.  AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARγ.

Authors:  Vedat Tiyerili; Ulrich M Becher; Adem Aksoy; Dieter Lütjohann; Sven Wassmann; Georg Nickenig; Cornelius F H Mueller
Journal:  Cardiovasc Diabetol       Date:  2013-02-01       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.